Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2015.07.017
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Salvage Systemic Therapy for Advanced Urothelial Carcinoma: On the Cusp of a Sea Change?

Oncologist
Cancer ResearchMedicineOncology
2015English

Salvage Pembrolizumab Added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Trimodality Therapy in Variant Urothelial Carcinoma: Choose Wisely

Translational Andrology and Urology
Reproductive MedicineUrology
2017English

Response of Serum Tumor Markers CA19-9 and bHCG to Cystectomy for Bladder Urothelial Carcinoma

Elyns Journal of Cancer Research
2016English

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Clinical Genitourinary Cancer
OncologyUrology
2015English

Learning From Errors: Response to Gefitinib in Kidney Urothelial Carcinoma With EGFR Mutations

Oncologist
Cancer ResearchMedicineOncology
2014English

Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin

Clinical Genitourinary Cancer
OncologyUrology
2015English

Could Salvage Surgery After Chemotherapy Have Clinical Impact on Cancer Survival of Patients With Metastatic Urothelial Carcinoma?

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2011English

Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy